See feature articles below:
About Broad Street Alerts:
Big opportunities in Small Cap’s
Broad Street Alerts recent profiles and track record, 217% in verifiable potential gains for our members on the last 4 small cap alerts alone!
February 10th, 2016- (NASDAQ: BONT) opened $1.65/share hit a high of $3.00/share within 30 days our member potential gains- 83%
March 7th, 2016-(NYSE-MKT: FSI) opened at .91/share and hit 1.10/share within 5 days for gains of 21% for our members.
March 24th, 2016- (NASDAQ: ICLD) opened at $.77/share it a high of $1.15/share within 2 days for gains of 49% for our members.
April 11th, 2016 – (NASDAQ: FNJN) called at $1.07/share hit $1.76/share in 3 days for 64% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business.
We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.
***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
–Report on:(Nasdaq: MCUR)
Below are the most recently updated broker updates which include ratings and price targets for Macrocure Ltd. (MCUR).
10/28/2015 – Broker: Jefferies Rating: hold New Target: 1.5 reiteration
10/28/2015 – Broker: Credit Suisse Rating: neutral New Target: 1 reiteration
08/20/2015 – Broker: Nomura Rating: neutral New Target: 6 downgrade
08/20/2015 – Broker: Oppenheimer Rating: perform downgrade
08/25/2014 – Broker: Credit Agricole Rating: outperform New Target: 15 newcoverage
The average price target from the most recent broker reports is 5.88
The stock decreased -3.06% (-0.03) during the last days session, reaching 0.95 and roughly 23394 shares were bought or sold by traders. Macrocure Ltd. (MCUR) has decreased by -90.40% over 12 months.
MacroCure Ltd. is a biotechnology company. The Company is focused on developing, manufacturing and commercializing cell therapy products to address unmet needs in the treatment of chronic and other hard-to-heal wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). Its product candidate, CureXcell, is an advanced wound care (AWC) therapy to treat such wounds by injecting living human white blood cells that have been activated to facilitate the healing process. CureXcell is in two pivotal, Phase 3, double-blind clinical trials targeting an indication for the treatment of DFUs and VLUs. The Company holds product approval for CureXcell as a medical device in Israel for the treatment of chronic and other hard-to-heal wounds.
View other investors thoughts on Macrocure Ltd. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.
Source:Risers and Fallers
Broad street alerts has not been compensated for the mention of any publicly traded companies in this article nor do we own positions in any of the companies in this article.
Broad Street Alerts was previously compensated eighteen thousand five hundred dollars by star media llc for the mention of FNJN however, that contract has expired.